RUNX-IN-2

• UNSPSC Description:

  RUNX-IN-2 (Compound Conjugate 3) covalently binds to the RUNX-binding sequences, and inhibits the binding of RUNX proteins to their target sites. RUNX-IN-2 induces the p53-dependent apoptosis and inhibits cancer cell growth. RUNX-IN-2 inhibits tumor growth in PANC-1 xenograft mice. RUNX-IN-2 has high alkylation efficiency and specificity[1].

• Target Antigen:

  Apoptosis

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/runx-in-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=NC(NC(CCNC(CCCC2=CC=C(N(CCCl)CCCl)C=C2)=O)=O)=CN1C)NC3=CN(C)C(C(NC4=CN(C)C(C(NC5=CN(C)C(C(NCCCC(NC6=CN(C)C(C(NC7=CN(C)C(C(NC8=CN(C)C(C(NC9=CN(C)C(C(NCCCN(C)C)=O)=C9)=O)=C8)=O)=C7)=O)=C6)=O)=O)=N5)=O)=C4)=O)=N3

• Molecular Weight:

  1524.52

• References & Citations:

  [1]Hirose Y, et al. Anticancer Activities of DNA-Alkylating Pyrrole-Imidazole Polyamide Analogs Targeting RUNX Transcription Factors against p53-Mutated Pancreatic Cancer PANC-1 Cells. J Med Chem. 2023 Sep 14;66(17):12059-12068.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2893777-88-1